SHS Gesellschaft für Beteiligungsmanagement mbH

News Current page: 21

Current news of SHS and our portfolio companies

SHS Newsletter

Would you like to receive regular updates about us and our portfolio? Are you interested in our latest investments and exits? Do you want to stay informed about trends in the healthcare market?

Then sign up for our newsletter!



Newsletter subscription

Please enable JavaScript in your browser to complete this form.
26. June 2020 - News

Ärzteblatt: “NMR-Spektroskopie: Abstoßung ohne Biopsie erkennen” (NMR spectroscopy: detecting rejection without biopsy)

A real improvement in kidney transplant rejection diagnostics: The transplantation of a organ (e.g. kidney) is a highly invasive procedure, a high risk but also chance for the patient and a huge burden for the body to process. Furthermore, current standards of diagnosis for the rejection risk of transplanted kidneys are invasive, not robust, and an additonal burden for the patient. This is changing now by using NMR spectroscopy as a reliable and cost efficient non invasive alternative. Would it not be good to have access to such methodology as a standard?

Read more
First Previous
...
1920
21
2223
...
Next Last